Correction to: Cell Death and Disease https://doi.org/10.1038/s41419-022-05439-8, published online 23 November 2022
In this article the affiliation of Qian Zhou has not given correctly. It should read: Department of neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Li, C., Wang, T., Gu, J. et al. Correction: SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma. Cell Death Dis 14, 411 (2023). https://doi.org/10.1038/s41419-023-05920-y
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-023-05920-y
